Lactobacillus helveticus SBT2171 alleviates allergic symptoms in a murine model for pollen allergy |
| |
| Authors: | Tomoyuki Makino Maya Yamashita Natsumi Takeuchi Toshihide Kabuki Makoto Hattori |
| |
| Institution: | 1. Department of Applied Biological Science, Tokyo University of Agriculture and Technology, Tokyo, Japan;2. Milk Science Research Institute, Megmilk Snow Brand Co., Ltd., Saitama, Japan |
| |
| Abstract: | ABSTRACTLactic acid bacteria are known to have various health-promoting effects and are highly expected to find applications in anti-allergic food materials. In this study, we focused on Lactobacillus helveticus SBT2171 (LH2171), which reportedly modifies some unique immune responses and ameliorated symptoms of patients allergic to mites and house dust in the previous studies. We examined the effect of LH2171 on cytokine production by antigen-stimulated murine naïve splenocytes in vitro and demonstrated that it inhibited IL-4 and IL-13 production while enhancing IFN-γ and IL-10 production. Then, we examined the anti-allergic effect of LH2171 in vivo using a murine model of pollen allergy and found that LH2171 reduced the sneezing frequency when orally administered to mice. We successfully confirmed the immune modulatory activity of LH2171 and its anti-allergic activity against inhaled antigens. These evidences would contribute to identifying the anti-allergic mechanism of LH2171.Abbreviations: ALDH: aldehyde dehydrogenase; EGCG: epigallocatechin gallate; LAB: lactic acid bacteria; LH2171: Lactobacillus helveticus SBT2171; NALT: nasal-associated lymphoid tissue; OVA: ovalbumin |
| |
| Keywords: | Lactic acid bacterium pollen allergy sneezing |
|
|
